Literature DB >> 1708002

Genealogy of the spontaneously hypertensive rat and Wistar-Kyoto rat strains: implications for studies of inherited hypertension.

W J Louis1, L G Howes.   

Abstract

The spontaneously hypertensive rat (SHR) is the most commonly used animal model of hypertension. For many years, it has been widely accepted that the most appropriate control strain is the Wistar-Kyoto (WKY) rat to which SHR rats are genetically related. However, recent concerns have been raised about genetic differences between the various colonies of SHRs and, in particular, genetic differences between colonies of WKY rats. It has been further emphasized that the only way to establish that a genetic trait is an etiological factor in the development of hypertension is through studies of F2 backcrosses between SHR and WKY rats. The present article details the history of the SHR and WKY strains and demonstrates why there is high likelihood of genetic variability between rats of both strains from different colonies around the world. It suggests that the WKY strain is not the most suitable for backcross studies because of the incidence of spontaneous hypertension and the somewhat higher levels of blood pressure in these rats. A central reference strain is proposed using SHRs inbred at Kyoto University, where brother/sister inbreeding has continued for more than 80 generations.

Entities:  

Mesh:

Year:  1990        PMID: 1708002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  26 in total

1.  Alveolar bone healing process in spontaneously hypertensive rats (SHR). A radiographic densitometry study.

Authors:  Natalia Manrique; Cassiano Costa Silva Pereira; Lourdes Maria Gonzáles Garcia; Samuel Micaroni; Antonio Augusto Ferreira de Carvalho; Sílvia Helena Venturoli Perri; Roberta Okamoto; Doris Hissako Sumida; Cristina Antoniali
Journal:  J Appl Oral Sci       Date:  2012 Mar-Apr       Impact factor: 2.698

2.  'Altered' mesenteric artery SK(Ca) : functional implications?

Authors:  Shaun Sandow; T Hilton Grayson
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Hypertension modifies OPG, RANK, and RANKL expression during the dental socket bone healing process in spontaneously hypertensive rats.

Authors:  Natalia Manrique; Cassiano Costa Silva Pereira; Eloá Rodrigues Luvizuto; Maria Del Pilar Rodriguez Sánchez; Tetuo Okamoto; Roberta Okamoto; Doris H Sumida; Cristina Antoniali
Journal:  Clin Oral Investig       Date:  2015-01-07       Impact factor: 3.573

4.  Presynaptic modulation of K+-evoked [3H]dopamine release in striatal and frontal cortical synaptosomes of normotensive and spontaneous-hypertensive rats.

Authors:  M A Yousfi-Alaoui; S Hospital; A Garcia-Sanz; A Badia; M V Clos
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

Review 5.  Animal models to guide clinical drug development in ADHD: lost in translation?

Authors:  Jeffery R Wickens; Brian I Hyland; Gail Tripp
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Distinct effects of early-life experience and trait aggression on cardiovascular reactivity and recovery.

Authors:  Samir Rana; Phyllis C Pugh; J Michael Wyss; Sarah M Clinton; Ilan A Kerman
Journal:  Physiol Behav       Date:  2018-12-04

Review 7.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

8.  Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modelling.

Authors:  N Snelder; B A Ploeger; O Luttringer; D F Rigel; F Fu; M Beil; D R Stanski; M Danhof
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

9.  Genetic architecture of Wistar-Kyoto rat and spontaneously hypertensive rat substrains from different sources.

Authors:  Yanli Zhang-James; Frank A Middleton; Stephen V Faraone
Journal:  Physiol Genomics       Date:  2013-05-14       Impact factor: 3.107

10.  Hepatocyte nuclear factor 1 and hypertensive nephropathy.

Authors:  Renata I Dmitrieva; Cruz A Hinojos; Eric Boerwinkle; Michael C Braun; Myriam Fornage; Peter A Doris
Journal:  Hypertension       Date:  2008-04-28       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.